Let's cut through the hype: what concretely changes for Series A funding of a company just because an article is published on arXiv? A simple research article, even with techniques like "path-retrieval" and "multi-perspective evidence fusion," does not guarantee that the actual cash flows of a startup will improve tomorrow. In France, the AMF and ACPR require tangible proof of commercial viability and regulatory compliance, not unproven academic models. A French investor will wait for a proof of concept and concrete execution before investing capital, not an algorithmic promise. For example, a French company raising funds must demonstrate a functional product and customer traction, well beyond any predictive framework.